What goes around comes around: Artificial circular RNAs bypass cellular antiviral responses

Patrick Barth, Yannic Noe, Lyudmila Shalamova, Alexander Goesmann, Friedemann Weber

Molecular Therapy — Nucleic Acids · 2022 · 37 citations · 52 references

DOIFull text

Open access

Concepts

Abstract

transcribed RNA in coronavirus disease 2019 (COVID-19) vaccines, the question arose whether therapeutic circular RNAs trigger cellular antiviral defense mechanisms when delivered systemically. In this study, we present data on the cellular innate immune response as a consequence of liposome-based transfection of the circular RNA sponges we previously used to inhibit microRNA function. We find that circular RNAs produced by the presented methodology do not trigger the antiviral response and do not activate innate immune-signaling pathways.

References

52